Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice
- 31 July 2009
- journal article
- Published by Elsevier BV in International Immunopharmacology
- Vol. 9 (7-8), 900-909
- https://doi.org/10.1016/j.intimp.2009.03.015
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Pathways Mediating the Expansion and Immunosuppressive Activity of Myeloid-Derived Suppressor Cells and Their Relevance to Cancer TherapyClinical Cancer Research, 2007
- Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancerNature Medicine, 2007
- Arginase, Prostaglandins, and Myeloid-Derived Suppressor Cells in Renal Cell CarcinomaClinical Cancer Research, 2007
- Myeloid suppressor cells regulate the adaptive immune response to cancerJCI Insight, 2006
- Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cellsJCI Insight, 2006
- Immunohistochemical and Genetic Evaluation of Deoxycytidine Kinase in Pancreatic Cancer: Relationship to Molecular Mechanisms of Gemcitabine Resistance and SurvivalClinical Cancer Research, 2006
- Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing HostCancer Research, 2006
- Regulation of immune responses by L-arginine metabolismNature Reviews Immunology, 2005
- An in vitro study of the inhibitory activity of gemcitabine and platinum agents in human endometrial carcinoma cell linesGynecologic Oncology, 2004
- Cyclophosphamide and abrogation of tumor-induced suppressor T cell activityCancer Immunology, Immunotherapy, 1990